Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$228K Sell
874
-2
-0.2% -$593 0.17% 81
2024
Q3
$282K Buy
876
+32
+4% +$10.5K 0.22% 70
2024
Q2
$264K Buy
844
+1
+0.1% +$294 0.22% 72
2024
Q1
$240K Sell
843
-1
-0.1% -$293 0.2% 78
2023
Q4
$243K Sell
844
-120
-12% -$32.7K 0.22% 70
2023
Q3
$259K Buy
964
+6
+0.6% +$1.5K 0.24% 66
2023
Q2
$213K Sell
958
-145
-13% -$33.6K 0.19% 78
2023
Q1
$267K Sell
1,103
-1
-0.1% -$245 0.25% 67
2022
Q4
$290K Sell
1,104
-61
-5% -$16.4K 0.29% 61
2022
Q3
$263K Sell
1,165
-601
-34% -$146K 0.3% 60
2022
Q2
$430K Hold
1,766
0.48% 44
2022
Q1
$427K Hold
1,766
0.4% 48
2021
Q4
$397K Buy
+1,766
New +$373K 0.37% 50

Other funds holding AMGN

Unionview LLC's AMGN Position: Q4 2024 in Review

Unionview LLC reduced its Amgen (AMGN) stake by 0.23% in Q4 2024, selling an estimated $593 and leaving 874 shares worth $228K. The position accounts for 0.17% of the portfolio, ranked #81.

Unionview LLC first reported a position in AMGN in Q4 2021 and has held it in 13 quarters since. The position peaked at $430K in Q2 2022. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Unionview LLC held 874 shares of Amgen worth $228K as of Q4 2024.
  • Unionview LLC sold 2 Amgen shares in Q4 2024, an estimated $593.
  • Amgen made up 0.17% of Unionview LLC's portfolio in Q4 2024, its #81 holding.
  • Unionview LLC first reported a position in Amgen in Q4 2021 and has held it in 13 quarters since.
  • Unionview LLC's Amgen position peaked at $430K in Q2 2022.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Unionview LLC's 13F filing for Q4 2024, filed 3 Feb 2025.